✦ LIBER ✦

Ribavirin treatment for chronic hepatitis C

✍ Scribed by Reichard, O.; Andersson, J.; Schvarcz, R.; Weiland, O.

Book ID: 121316547
Publisher: The Lancet
Year: 1991
Tongue: English
Weight: 529 KB
Volume: 337
Category: Article
ISSN: 0140-6736
DOI: 10.1016/0140-6736(91)91707-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retinopathy associated with pegylated in

Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C

✍ Shelly Adams; Mark Ostermeier 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 995 KB

Interferon and ribavirin treatment for c

Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease

✍ Luigi E Adinolfi; Emanuele Durante Mangoni; Augusto Andreana 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 49 KB

Pleural effusion associated with pegylat

Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C

✍ Amit Arora; Leonardo Vargas; Tomasz J. Kuzniar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Lung toxicity related to interferon (IFN) alpha typically takes a form of interstitial pneumonitis, granulomatous inflammation, or organizing pneumonia. We report a case of a 52‐year‐old woman, who developed pneumonitis with exudative, lymphocytic‐predominant pleural effusion following

Cutaneous adverse drug reaction to pegyl

Cutaneous adverse drug reaction to pegylated interferons during peginterferon alpha and ribavirin treatment for chronic hepatitis C

✍ Kinaciyan, T.; Jessner, W.; Formann, E.; Hayek, B.; Steindl-Munda, P.; Ferenci, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Modifications of T-Lymphocyte Subsets be

Modifications of T-Lymphocyte Subsets before and during Interferon and Ribavirin Treatment for Chronic Hepatitis C Infection

✍ Neau-Cransac, Martine; Foucher, Juliette; Ledinghen, Victor De; Bernard, Pierre- 📂 Article 📅 2005 🏛 Mary Ann Liebert 🌐 English ⚖ 94 KB

Adherence to PEG/ribavirin treatment for

Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence

✍ Evon, D. M.; Esserman, D. A.; Bonner, J. E.; Rao, T.; Fried, M. W.; Golin, C. E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB